We are DHIT.
A social purpose venture dedicated to driving healthcare transformation through our digital health impact platform. We connect people and emerging technologies, matching ecosystem needs with validated solutions through demand-driven collaboration and innovation to transform the way we treat, cure, care, live. Our platform is driven by Impact Committees that identify the highest unmet health needs in a community and generate demand blueprints. These blueprints are exposed to digital health innovators to guide and validate their solutions in real-world settings which we call Impact Centers. Our Impact Fund is used to accelerate and amplify results for opportunities that present the highest potential.
DHIT – Driving digital health innovation to impact.
Michael is a passionate healthcare executive turned digital health evangelist and entrepreneur. In addition to co-founding Bluedoor, Michael has served as Entrepreneur-in-Residence for the Center for Health Innovation at the University of North Carolina at Chapel Hill, where he has designed and developed their Digital Health Program in support of UNC’s Digital Transformation strategy. Prior to Bluedoor and UNC, Michael was Co-founder and COO of Digital Therapy, a cognitive computing platform powered by IBM Watson in the behavioral health space. His previous leadership roles include Vice Chair of Administration for the Department of Medicine at the University of Miami Health System, engineering a $15 million turnaround within his first year; and Director of Clinical Operations for UNC Health Care’s specialty ambulatory clinics where continued growth and expansion were achieved. Michael also held several leadership roles at UCLA Health within various clinical departments. He has a BSc in Neuroscience from Tulane University in New Orleans and an MBA from Elon University in North Carolina.
Lee is a seasoned innovator and strategist with more than 25 years’ experience in Europe, the US and Asian markets. He has previously worked in senior management roles for global brands including Vodafone and Harrods, and has led creative agencies in Tokyo and London. For the last 12 years he has specialized in the health sector, leading branding and consumer product innovation projects for organizations including US healthcare giant Humana, global telehealth-care company Tunstall, and major US health systems. Lee is an expert in consumer engagement and behavior change marketing, and pioneered population health management strategies in the UK’s NHS. In addition to co-founding Bluedoor, he is a Co-founder and Fellow of The Institute of Healthcare Design Thinking. Lee holds a BA and MA in Oriental Studies from Cambridge University, UK.
As the previous Global Head of Commercialization at IBM Watson Health, Don has 25 years of experience commercializing transformative and award winning innovations on a global basis. His experience ranges from serving in leadership roles at fortune 50 multi-national technology companies, to serving as Chairman, CEO, and various C-level roles for early and growth-stage ventures. Don has played key roles in rapidly building several billion dollar businesses, driving business expansion across 140+ countries, forming a broad range of strategic alliances and partnerships, and successfully managing numerous M&A transactions. He has led the development of go-to-market strategies to penetrate emerging markets and managed global sales and marketing organizations that produced geometric growth across established markets. Don is a frequent keynote speaker on healthcare transformation, precision medicine, and digital health, lectures at top universities on healthcare commercialization and entrepreneurship, and serves on numerous healthcare industry expert panels, boards, and steering committees.
Dr. Jonathan Lord, also known as Jack, serves as the Chairman of the Board at BIOLASE, Inc. since September 2017. Dr. Lord joined Humana Inc. in 2000 and served as Chief Innovation Officer until April 2009 and also served as Senior Vice President. With more than 20 years in medical administration, he joined Humana from Health Dialog, where he served as president and became a leader in e-enabled healthcare. Prior to joining Health Dialog, he served as Chief Operating Officer of the American Hospital Association in Washington, D.C., Executive Vice President of Anne Arundel Medical Center in Annapolis, MD, and Executive Vice President of Sun Health in Charlotte, NC. Dr. Lord serves on the Advisory Board to the Director of the CDC, and the World Economic Forums Global Agenda Council on Chronic Disease and Malnutrition. He served as a Director for Stericycle (SRCL). From 2008 to 2017, Dr. Lord served on the board of directors of DexCom, Inc. and from 2010 to 2017, he served as its Chairman. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists.
Cindy is a Senior Executive and Attorney with over 25 years of experience developing and delivering innovative solutions to organizational challenges in complex multi-billion dollar private and public organizations. She is recognized for managing high performing teams that consistently create groundbreaking results. Cindy served as COO of the American Diabetes Association and was the Chief Ethics, Diversity and Accountability Officer with U.S. Foodservice. In 2008, she developed the first nationwide corporate philanthropy program at U.S. Foodservice aimed at eradicating hunger in the United States. This program, Full Plates Full Lives, raised more than $4 million in cash and product donations for Feeding America. Cindy holds a Bachelor of Science in Social Work from the University of North Carolina at Greensboro, and a law degree from Antioch University.
Jodi Hubler delivers a unique combination of executive leadership and venture capital investing expertise with direct experience in operations, governance, human capital, culture change, negotiations, and strategic planning and execution. She is recognized for her keen insight, direct approach, and skillful stewardship of organizations from incubated start-ups to multi-billion-dollar corporations. As Managing Director of Lemhi Ventures, a health care services venture capital fund with $385M under management, she leads an experienced team in all aspects of the investment life cycle. Over her 24-year career, she has held executive positions in a variety of public and private companies, including a lead role in global human resource re-engineering efforts for Cargill; driving systems to support lean manufacturing and process change for a $2B division of Alcoa; and start-up experience with venture-backed Definity Health, where she served as chief people officer. Jodi is a frequent panelist at conferences and is a member of the Healthcare Executives Leadership Network and Women Business Leaders in Healthcare (WBL).
Dr. Ginsburg has pioneered translational genomics, initiating programs in genome enabled biomarker discovery, longitudinal registries with linked molecular and clinical data, biomarker-informed clinical trials, and the development of novel practice models and implementation research for the integration of genomic tools in health care systems. He has led the development of predictive models for common complex diseases using high dimensional genomic data and collaborates with engineering groups to develop novel point of care sensors. He is an internationally recognized expert in genomics and personalized medicine with over 200 published papers, and funding from NIH, DOD, DARPA, the Gates Foundation, and industry.
We are in the process of forming IMPACT Committees across the following key domains. These Committees will be responsible for translating digital health ecosystem potential into measurable outcomes via action oriented collaboration.